JP Morgan analyst Richard Sunderland downgrades New Jersey Resources (NYSE:NJR) from Neutral to Underweight and lowers the price target from $47 to $46.
Companies Reporting Before The Bell
• Mirum Pharmaceuticals (NASDAQ:MIRM) is expected to report quarterly loss at $1.34 per share on revenue of $8.46 million.
New Jersey Resources (NYSE:NJR) reported quarterly earnings of $0.69 per share which missed the analyst consensus estimate of $0.72 by 4.17 percent. This is a 50 percent increase over earnings of $0.46 per share from the
New Jersey Resources (NYSE:NJR) reported quarterly earnings of $0.07 per share which missed the analyst consensus estimate of $0.08 by 12.5 percent. This is a 87.72 percent decrease over earnings of $0.57 per share from
New Jersey Resources (NYSE:NJR) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.11) by 54.55 percent. This is a 16.67 percent increase over losses of $(0.06) per share from